Takeda Pharmaceutical Co. Ltd. - Net Income From Continuing Operations

Takeda Pharmaceutical Co. Ltd.'s Fiscal Year is From April To March - All Figures are in JPY, Billions.

The item "Net-Income-From-Continuing-Operations" stands at 33.29 Billion Japanese Yens for the trailing twelve months (TTM) period ending 09/30/2025, the lowest value since 06/30/2020.

Takeda Pharmaceutical Co. Ltd.'s second quarter result of -11.73 Billion JPY for the item "Net Income From Continuing Operations" represents a decrease of -109.44 percent compared to it's first quarter result.

Also, Takeda Pharmaceutical Co. Ltd.'s second quarter result of -11.73 Billion JPY for the item "Net Income From Continuing Operations" represents a decrease of -112.73 percent compared to it's second quarter result of last year.

Looking again at the trailing twelve months series (TTM), Takeda Pharmaceutical Co. Ltd.'s second quarter result of 33.29 Billion JPY for the item "Net Income From Continuing Operations" represents a decrease of -75.72 percent compared to it's first quarter result.


Regarding the One-Year-Change of the series, the current value constitutes an decrease of -256.88 Billion Japanese Yens compared to the value the year prior.
The 1 year change is -256.88 Billion Japanese Yens.
The 3 year change is -179.91 Billion Japanese Yens.
The 5 year change is -22.76 Billion Japanese Yens.

The Serie's long term average value is 181.62 Billion Japanese Yens. It's latest available value, on 09/30/2025, is -148.33 Billion Japanese Yens lower, compared to it's long term average value.
The Serie's change in Japanese Yens from it's minimum value, on 12/31/2019, to it's latest available value, on 09/30/2025, is +87.45 Billion.
The Serie's change in Japanese Yens from it's maximum value, on 09/30/2021, to it's latest available value, on 09/30/2025, is -502.71 Billion.